Conference abstract · 23 Mar 2015
EditorialPublished 31 May 2021
Chemo-resistant Leukemia Cells
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Leukemia, positioning the primary spot in youthful individuals' harmful infections, is the dangerous tumor of hematopoietic framework. As of now, chemotherapy is still a significant treatment strategy for leukemia. However with the utilization of chemotherapy drugs, leukemia cells step by step create opposition coming about in chemotherapy disappointment. The acquired (regular) or procured drug opposition, particularly multidrug opposition (MDR) is viewed as the significant reason for chemotherapy disappointment. In spite of unmistakable components, MDR is generally the helpful impact of a mix of MDR systems like obstructing apoptosis and expanding drug efflux. Among drug efflux carriers, the most broadly examined is adenosine triphosphate-restricting tape (ABC) carriers
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 8 Aug 2016
Screening chemo-resistant related genes via digital gene expression profiling and small RNA sequencing in esophageal squamous cell carcinoma
Review article · 28 Apr 2023
Gemcitabine and Triapine Co-Delivery Using Calcium Carbonate Nanoparticles for the Treatment of Chemo-resistant Pancreatic Cancer
Research article · 22 Jun 2022
Long Non-Coding Ribonucleic Acid Disrupted in Renal Carcinoma 3 Inhibits Chemo-Resistance of Prostate Cancer via MicroRNA-24-3p/KIT Ligand Axis
Review article · 2020
High-Level of Notch 1/Jagged 1 Level up Regulated Chemo-Resistance of Cisplatin in NSCLC
More from this journal
The newest in Journal of Cancer Clinical Trials.
Article · 26 Oct 2026
Leveraging Artificial Intelligence to Structure Next-Generation Sequencing Data for Precision Oncology Research: A Real-World Pancreatic Ductal Adenocarcinoma Liquid Biopsy Experience
Article · 3 Jul 2026
The Current Status of Adjuvant Chemotherapy for Colorectal Cancer in Japan: A Paradigm Shift from Oral Fluoropyrimidine Monotherapy to Oxaliplatin-Based Regimens
Brief report · 29 Dec 2025
Validating Cancer Biomarkers: Challenges and Precision Medicine
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Cancer Clinical Trials
- SubjectOncology & Cancer
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Thomas Kalhor”

